CYTEK BIOSCIENCES, INC. Cash and Cash Equivalents
CYTEK BIOSCIENCES, INC. (CTKB) had Cash and Cash Equivalents of $73.85 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $73.85M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $65.67M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $90.85M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $93.28M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $73.85M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $65.67M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $90.85M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $93.28M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $75.47M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $95.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $98.72M 10-K · filed 2026-02-26 |
| 2024-09-30 | $162.27M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $177.89M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $168.79M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $167.30M 10-K · filed 2025-02-28 |
| 2023-09-30 | $163.63M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $131.54M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $129.48M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $296.60M 10-K · filed 2024-03-13 |
| 2022-09-30 | $341.52M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $349.89M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $362.51M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $364.62M 10-K · filed 2023-03-01 |
| 2021-09-30 | $376.77M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $159.85M 10-Q · filed 2021-09-03 |
| 2020-12-31 | $165.23M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |